ArticleFrontiers in oncology2026
An optimized EfficientNetB7 deep learning model for lung cancer tissue pathology image recognition.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is the leading cause of cancer deaths worldwide. This study constructed and optimized a deep learning model to recognize lung cancer pathological images for intelligent classification. Methods: The LC25000 dataset was adopted for model training, and the LungHist700 dataset served as independent validation, with validation F1 score as the primary evaluation metric. Nine classic convolutional neural networks (DenseNet201, EfficientNetB7, EfficientNetV2S, InceptionResNetV2, MobileNetV3Large, NASNetLarge, ResNet50V2, VGG19, and Xception) were first benchmarked. Afterwards, three ensemble strategies including Equal-Weighted Averaging, Performance-Weighted Averaging and XGBoost were tested. Meanwhile, hyperparameter tuning was implemented on the optimal single model. Result: All nine baseline models obtained good performance on training and internal test datasets. Among individual models, EfficientNetB7 performed best with an F1 score of 0.891 and AUC of 0.749. Ensemble methods only reached a maximum F1 of 0.889, showing no obvious advantage over the best single model. By contrast, the hyperparameter-optimized EfficientNetB7 achieved remarkable generalization improvement, with accuracy 0.873, precision 0.864, recall 0.999, F1 score0.926 and AUC 0.871. Conclusion: The optimized model effectively recognizes lung cancer pathological images and supplies technical support for intelligent diagnosis. Multi-center large-sample clinical validation is required for future clinical transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.